A
Description
AmbioPharm is a global peptide CDMO specializing in peptide API manufacturing, headquartered in North Augusta, South Carolina. Founded in 2005, it operates FDA-inspected facilities with 463,000+ sq ft of space (US and Shanghai campuses), making it one of the world's largest peptide CDMOs. It employs 500+ professionals and uses solid-phase, solution-phase, and hybrid chemistry approaches.